Oxford BioMedica (
OTCMKTS:OXBDF -
Get Free Report) was the recipient of a significant drop in short interest in September. As of September 15th, there was short interest totaling 174,100 shares, a drop of 26.8% from the August 31st total of 238,000 shares. Based on an average daily volume of 100 shares, the days-to-cover ratio is currently 1,741.0 days. Based on an average daily volume of 100 shares, the days-to-cover ratio is currently 1,741.0 days.
Oxford BioMedica Price Performance
OTCMKTS OXBDF opened at $7.91 on Tuesday. Oxford BioMedica has a 12 month low of $3.15 and a 12 month high of $8.26. The stock's 50 day moving average is $7.12 and its 200 day moving average is $5.19.
Oxford BioMedica Company Profile
(
Get Free Report)
Oxford Biomedica plc, a contract development and manufacturing organization, focuses on delivering therapies to patients worldwide. Its s LentiVector platform technology is an advanced lentiviral vector based gene delivery system which is designed to overcome the safety and delivery problems associated with earlier generations of vector systems.
Featured Stories
This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider Oxford BioMedica, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Oxford BioMedica wasn't on the list.
While Oxford BioMedica currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Enter your email address and we'll send you MarketBeat's list of seven best retirement stocks and why they should be in your portfolio.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.